Quantcast

Pharma news

Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi®) as a Treatment for Patients with COVID-19 Associated Cytokine Storm

– Incyte also intends to launch an Expanded Access Program in the United States to allow eligible patients with COVID-19

Posted in news | Leave a comment

Simulations Plus Sets Date for 2nd Quarter 2020 Earnings Release and Conference Call

Conference Call to be on Thursday, April 9, 2020, at 4:15 PM ET LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP)

Posted in news | Leave a comment

Savara Obtains Global Rights to Develop and Commercialize Apulmiq

Management to Host Conference Call / Webcast with Bronchiectasis Expert Dr. James Chalmers AUSTIN, Texas–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), an

Posted in news | Leave a comment

Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the completion of its acquisition of the core assets of Icagen’s North

Posted in news | Leave a comment

Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody

Posted in news | Leave a comment

Premier Inc. Pursues Crucial Strategies to Get Supplies, Enable Care Delivery During COVID-19

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is coordinating across the industry to help solve the

Posted in news | Leave a comment

Hygiena launches all-in-one Listeria, L. monocytogenes detection method

Hygiena, a global leader in rapid microbial detection, monitoring, and identification technology, introduced the InSite L. mono Glo Environmental Surface Screening Test. InSite L. mono Glo Environmental Surface Screening Test. InSite L. monoGlo is an easy-to-use, self-contained, environmental sampling and screening test for Listeria species and Listeria monocytogenes (L. mono).

Posted in Europe, news | Tagged | Leave a comment

PBOA vs COVID-19: Pharma & biopharma industry and supply chain have positive outlook

The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19. PBOA’s members provide a wide array of services throughout the bio/pharma sector.

Posted in Europe, news | Tagged , , | Leave a comment

MJH Life Sciences™ Acquires the Pharmacy Benefit Management Institute (PBMI)

CRANBURY, N.J.–(BUSINESS WIRE)–#drugcostmanagement–MJH Life Sciences™ has announced it has acquired the Pharmacy Benefit Management Institute (PBMI) from Pharmaceutical Strategies Group

Posted in news | Leave a comment

Accelerated Enrollment Solutions and Science 37 Collaborate to Provide Virtual Trial Access to Patients Globally

Also offers immediate telehealth options for clinical trials in response to need for social distancing and business continuity during COVID-19

Posted in news | Leave a comment

Eisai, Biogen kick-off phase 3 testing early Alzheimer’s disease antibody, amid dropping aducanunab trial. Eisai’s US company presents AD pipeline

Eisai Co said Friday thata global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer’s disease has been initiated.

Posted in Approval, Asia, Europe, North America, Regions | Tagged , , | Leave a comment

ProMIS offeri potential significant advantage over aducanumab, learns from mistakes

ProMIS Neurosciencesissued a pres release Friday, raising urgency to selectively target the toxic oligomer with exacting precision as part of the global effort to develop disease-modifying therapies for Alzheimer’s disease (AD), upon Biogen’s and Eisai’s dropping two alte-stage clinical trials of aducanumab.

Posted in Approval, North America | Tagged , , , , | Leave a comment

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

Posted in Approval, Asia, Europe, news | Tagged , , | Leave a comment

Gelesis Announces Three Presentations at Annual Endocrine Society Meeting

BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI)

Posted in Approval, news, North America | Tagged | Leave a comment

CB Therapeutics Secures new Research and Production Facility

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes its

Posted in Approval, news | Tagged | Leave a comment

Vaxart Announces Closing of Registered Direct Offering of Common Stock

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather

Posted in Approval, news, North America | Tagged | Leave a comment

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute

STERLING, Kan.–(BUSINESS WIRE)–Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient

Posted in Approval, news, North America, Regions | Tagged , , , , | Leave a comment

Transgene: A Positive 2018, Moving Ahead with a Strong Portfolio

2018 Full-year results and business update Clinical trials set to announce key data in 2019 Invir.IO™ platform designed to deliver

Posted in Approval, news | Tagged | Leave a comment

Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai

SHANGHAI–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Shanghai?src=hash" target="_blank"gt;#Shanghailt;/agt;–To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center

Posted in Approval, Asia, news, Regions | Tagged | Leave a comment

MichBio Announces 7th Annual “Michigan Biosciences Day at the Capitol,” Seeks Participants

ANN ARBOR, Mich. & LANSING, Mich.–(BUSINESS WIRE)–Michigan’s premier biosciences industry trade organization, MichBio, presents its annual Michigan Biosciences Day at

Posted in Approval, news | Tagged | Leave a comment